A comprehensive view of moderna inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Moderna to report first quarter 2024 financial results on Thursday, May 2, 2024
Published:
April 17, 2024
by Moderna Inc.
|
Pfizer and BioNTech get temporary reprieve in patent dispute with Moderna, allowing more time for the Patent Trial and Appeal Board to review challenges; Pfizer and BioNTech’s COVID-19 vaccine to remain on the market despite lawsuit
Published:
April 15, 2024
by FiercePharma
|
Patent Application Titled 'Variant Strain-Based Coronavirus Vaccines' Published Online (USPTO 20240100151)
Published:
April 12, 2024
by CDC & FDA Daily
|
Moderna halts construction of planned vaccine manufacturing facility in Kenya due to post-pandemic decrease in COVID-19 vaccine demand; reports losses of over $1.0B to lack of African orders since 2022
Published:
April 11, 2024
by Nairametrics (Nigeria)
|
Moderna's COVID-19 vaccine, mRNA-1273, proves safe and effective in solid organ transplant recipients in Phase 3b trial; the trial shows that three doses of the vaccine elicited improved neutralizing antibody responses among these high-risk individuals
Published:
April 09, 2024
by Vaccine Daily
|
Ask us about our Health Care Sector market view